Lasa Supergenerics: Open offer in focus

| Updated on December 02, 2019 Published on December 03, 2019

Shares of Lasa Supergenerics will remain in focus in the markets, as an open offer made by Omkar Pravin Herlekar, promoter, is currently on.

The promoter plans to acquire up to 1.05 crore shares, representing 26 per cent of the emerging voting share capital, from eligible equity shareholders at ₹18.25 a share. The offer is mandatory as a preferential issue to Herlekar has increased his stake in the company to 63.23 per cent from 34.60 per cent. The offer ends on December 13.

Published on December 03, 2019
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.